(FM) Medicina Interna
Departamento académico
Academic Medical Center
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de Academic Medical Center (22)
2024
-
Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial
United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1016-1027
2023
-
Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies
Journal of the American Heart Association, Vol. 12, Núm. 12, pp. e027657
-
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
JHEP Reports, Vol. 5, Núm. 5
-
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients
Journal of Cachexia, Sarcopenia and Muscle, Vol. 14, Núm. 5, pp. 2301-2309
2022
-
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 13, pp. 4716-4726
-
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
Journal of Cancer Research and Clinical Oncology, Vol. 148, Núm. 2, pp. 475-485
-
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score
Thrombosis and Haemostasis, Vol. 122, Núm. 5, pp. 818-829
-
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial
Journal of Cancer Research and Clinical Oncology, Vol. 148, Núm. 9, pp. 2487-2496
-
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
The Lancet, Vol. 399, Núm. 10319, pp. 61-116
-
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?
Journal for immunotherapy of cancer, Vol. 10, Núm. 5
2021
-
Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization
EJNMMI Research, Vol. 11, Núm. 1
2020
-
Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data
ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10
-
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach
Hepatology, Vol. 72, Núm. 1, pp. 198-212
-
Sex differences between women and men with COPD: A new analysis of the 3CIA study
Respiratory Medicine, Vol. 171
-
The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale
Gerontology, Vol. 66, Núm. 5, pp. 447-459
2018
2017
-
A simple algorithm for the identification of clinical COPD phenotypes
European Respiratory Journal, Vol. 50, Núm. 5
2015
-
CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis
Oncotarget, Vol. 6, Núm. 30, pp. 28588-28606
-
Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: Analysis of the European multicentre trial SORAMIC
Liver International, Vol. 35, Núm. 2, pp. 620-626
2014
-
Anion exchanger 2 is critical for CD8+ T cells to maintain pHi homeostasis and modulate immune responses
European Journal of Immunology, Vol. 44, Núm. 5, pp. 1341-1351